The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model

EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme

(2013) Bryan W. Day et al.   CANCER CELL

Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma

(2013) Roxana Magaña-Maldonado et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas

(2012) Angela Ruban et al.   INVESTIGATIONAL NEW DRUGS

Activation of Rho GTPases Triggers Structural Remodeling and Functional Plasticity in the Adult Rat Visual Cortex

(2011) C. Cerri et al.   JOURNAL OF NEUROSCIENCE

Bacterial protein toxins that modify host regulatory GTPases

(2011) Klaus Aktories   NATURE REVIEWS MICROBIOLOGY

Modulation of RhoGTPases Improves the Behavioral Phenotype and Reverses Astrocytic Deficits in a Mouse Model of Rett Syndrome

(2011) Bianca De Filippis et al.   NEUROPSYCHOPHARMACOLOGY

Advances in the Treatment of Malignant Gliomas

(2010) Mustafa Khasraw et al.   Current Oncology Reports

Targeted Toxins in Brain Tumor Therapy

(2010) Yan Michael Li et al.   Toxins

Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1): Toxin Biology, in Vivo Applications and Therapeutic Potential

(2010) Alessia Fabbri et al.   Toxins

Functional Masking of Deprived Eye Responses by Callosal Input during Ocular Dominance Plasticity

(2009) Laura Restani et al.   NEURON

The Rho-activating CNF1 toxin from pathogenic E. coli: A risk factor for human cancer development?

(2008) Sara Travaglione et al.   Infectious Agents and Cancer